DDX43 mRNA expression and protein levels in relation to clinicopathological profile of breast cancer.

Noha N AmerRabab KhairatAmal M HammadMahmoud M Kamel

Published in: PloS one (2023)

This study explored the potential of using blood DDX43 mRNA expression or protein levels, or both in clinical settings as a marker of disease progression in human breast cancer. DDX43 mRNA expression proposes a less invasive method for discriminating benign from malignant BC.

Keyphrases

endothelial cells
protein protein
induced pluripotent stem cells
climate change
breast cancer risk